Phase IIa exploratory study to assess the safety and effect of IFNa-Kinoid (IFN-K) in adult patients with Dermatomyositis Phase IIa exploratory study to assess the safety and effect of IFNa-Kinoid (IFN-K) in adult patients ...
A Phase IIa, Single Blind, Randomized, Study to Evaluate the Safety, the Immunogenicity, and the Clinical and Biological Efficacy of IFNa-Kinoid (IFN-K) in Adult Subjects with Dermatomyositis. A Phase IIa, Single Blind, Randomized, Study to Evaluate the Safety, the Immunogenicity, and the Cli ...
Product Name: IFNa-Kinoid Product Code: IFN-K INN or Proposed INN: Not yet assigned Other descriptive name: IFN-Kinoid Drug SubstanceProduct Name: IFNa-Kinoid Product Code: IFN-K INN or Proposed INN: Not yet assigned Other descriptive n ...
Neovacs SA
NULL
Not Recruiting
Female: yes Male: yes
30
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...